Global Pain Management Drugs (Opioids, NSAIDs, Anti-Migraine, Anticonvulsants) Market, 2021


Dublin, June 20, 2017 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "Global Pain Management Drugs Market: Analysis By Type (Opioids, NSAIDs, Anti-Migraine, Anticonvulsants), By Application, By Region, By Country: Opportunities and Forecast (2011-2021)" report to their offering.

The global market is projected to display a robust growth represented by a CAGR of 4.96% during 2016- 2021, chiefly driven by large number of drugs in pipeline, rising number of chronically ill patients, new reforms and regulations in the consumption of medical cannabis.

Over the recent years, the global pain management drugs industry has been growing rapidly with the increasing demand for drugs which are used for the treatment of chronic pain conditions of neck, lower back, shoulders, post-operative pain, and pain during the sports injuries. Globally, the growth in the pain management drugs market is driven by large number of chronically ill patients, rise in global incidences of cancer and strong presence of pipeline drugs used for chronically ill conditions.

The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global food service equipment market. Additionally, the report also highlights market entry strategies for various companies across the globe.

Scope of the Report

Global Market (Actual Period: 2011-2015, Forecast Period: 2016E-2021F)

- Pain Management Drugs Market
- By Type of Drugs
- Application Market
- Drug Pipeline - By Developer, Phase, Indication and Status

Regional Markets - N. America, Europe, APAC, Latin America, RoW (Actual Period: 2011-2015, Forecast Period: 2016E-2021F)

- Pain Management Drugs Market
- By Type of Drugs

Country Analysis - US, Canada, UK, Germany, France, Japan, China, India, Brazil, Mexico (Actual Period: 2011-2015, Forecast Period: 2016E-2021F)

- Pain Management Drugs Market

Other Report Highlights

- Market Dynamics - Trends, Drivers, Challenges
- Policy and Regulation
- Company Analysis - Endo Pharmaceuticals, AstraZeneca, Novartis , Purdue Pharma, GSK, Tetra Bio Pharma, Allergen, Boehringer-Ingelheim, Sanofi, Pfizer

Key Topics Covered:

1. Research Methodology

2. Executive Summary

3. Strategic Recommendation

4. Pain Management Drugs Market Outlook

5. Global Pain Management Drugs Market: Growth and Forecast

6. Global Pain Management Drugs Market: By Region

7. North America Pain Management Drugs Market

8. North America Pain Management Drugs Market, By Country

9. North America Pain Management Drugs Market: By Type

10. Europe Pain Management Drugs Market

11. Europe Pain Management Drugs Market, By Country

12. Europe Pain Management Drugs Market: By Type

13. Asia Pacific Pain Management Drugs Management Market

14. Asia Pacific Pain Management Drugs Market, By Country

15. Asia Pacific Drug Pain Management Market: By Type

16. Latin America Pain Management Drugs Market

17. Latin America Pain Management Drugs Market, By Country

18. Latin America Pain Management Drugs Market: By Type

19. ROW Pain Management Drugs Market

20. Market Dynamics

21. Company Profiles

22. Pipeline Analysis

Companies Mentioned

- Allergan
- Astrazeneca plc
- Boehringer Ingelheim
- Endo Pharmaceuticals
- Glaxosmithkline
- Novartis
- Pfizer
- Purdue Pharma
- Sanofi
- Tetra Bio Pharma

For more information about this report visit https://www.researchandmarkets.com/research/2zn69x/global_pain



            

Contact Data